Association of cytokines in hepatitis E with pregnancy outcome

Cytokine

Volumn 65, Issue 1, 2014, Pages 95-104

  Kumar, Ashok ^a   Devi, Salam Gyaneshwori ^a   Kar, Premashis ^a   Agarwal, Sarita ^a   Husain, Syed Akhtar ^b   Gupta, Ram Kumar ^a   Sharma, Shashi ^c  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^c INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

Author keywords

Hepatitis E virus; Interferon ; Interleukin 6; Transforming growth factor ; Tumour necrosis factor

Indexed keywords

BILIRUBIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FULMINANT HEPATIC FAILURE; GESTATIONAL AGE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTHROMBIN TIME; REAL TIME POLYMERASE CHAIN REACTION; VIRUS IDENTIFICATION; VIRUS LOAD;

HEPATITIS E VIRUS;

ADULT; BILIRUBIN; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; LIVER FAILURE, ACUTE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PROTHROMBIN TIME; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD; YOUNG ADULT;

EID: 84888205518     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.09.022     Document Type: Article

References (40)

1. Khuroo M.S., Teli M.R., Skidmore S., Soa M.A., Khuroo M.I. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981, 70:252-255.
2. Khuroo M.S., Kamili S., Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995, 345:1025-1026.
3. Kumar R.M., Uduman S., Rana S., Kochiyil J.K., Usmani A., Thomas L. Sero-prevalence and motherto-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Ret Gynaec Rep Biol 2001, 100:9-15.
4. Jilani N., Das B.C., Husain S.A., Baweja U.K., Chattopadhya D., Gupta R.K., et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol 2007, 22:676-682.
5. Pal R., Aggarwal R., Naik S.R., Das V., Das S., Naik S. Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol 2005, 20:1094-1101.
6. Andus T., Bauer J., Gerok W. Effect of cytokines on the liver. Hepatology 1991, 13:364-375.
7. Dinarello C.A. Interleukin-l and interleukin-l antagonism. Blood 1991, 77:1627-1652.
8. Anastassakos C., Alexander G.J.M., Wolstencroft R.A., Avery J.A., Portmann B.C., Panayi G.S., et al. Interleukin-l and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 1988, 94:999-1005.
9. Yoshioka K., Kakumu S., Arao M., Tstusumi Y., Inoue M. Tumor necrosis factor-e production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989, 10:769-773.
10. Kakumu S., Shinagawa T., Ishikawa T., Yoshioka K., Wakita T., Ito Y., et al. Serum interleukin-6 levels in patients with chronic hepatitis B. Am J Gastroenterol 1991, 86:1804-1808.
11. Brockhaus M., Schoenfeld H.J., Schlaeger E.J., Hunziker W., Lesslauer W., Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990, 87:3127-3131.
12. Hunt J.S., Chen H.L., Miller L. Tumor necrosis factors: pivotal components of pregnancy?. Biol Reprod 1996, 54:554-562.
13. Clark D.A., Chaouat G., Arck P.C., Mittruecker H.W., Levy G.A. Cytokine-dependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J Immunol 1998, 160:545-549.
14. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997, 18:478-482.
15. Haimovici F., Hill J.A., Anderson D.J. The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol Reprod 1991, 44:69-75.
16. Robertson S.A., Seamark R.F., Guilbert L.J., Wegmann T.G. The role of cytokines in gestation. Crit Rev Immunol 1994, 14:239-292.
17. Mitchell M.D., Dudley D.J., Edwin S.S., Schiller S.L. Interleukin 6 stimulates prostaglandin production by human amnion and decidual cells. Eur J Pharmacol 1991, 192:189-191.
18. Fukuda H., Masuzaki H., Ishimaru T. Interleukin-6 and interleukin-1 receptor antagonist in amniotic fluid and cord blood in patients with pre-term, premature rupture of the membranes. Int J Gynaecol Obstet 2002, 77:123-129.
19. Jones R.L., Stoikos C., Findlay J.K., Salamonsen L.A. TGF-beta superfamily expression and actions in the endometrium and placenta. Reproduction 2006, 132:217-232.
20. Lin H., Mosmann T.R., Guilbert T., Tuntipopipat S., Wengmann T.G. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993, 151:4562-4573.
21. Akpolat N., Yahsi S., Godekmerdan A., Demirbag K., Yalniz M. Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B. World J Gastroenterol 2005, 11:3260-3263.
22. Wang J.Y., Wang X.L., Liu P. Detection of serum TNF-alpha, IFN-beta, IL-6 and IL-8 in patients with hepatitis B. World J Gastroenterol 1999, 5:38-40.
23. Huang Y.S., Hwang S.J., Chan C.Y., Wu J.C., Chao Y., Chang F.Y., et al. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. Zhonghua Yi Xue Za Zhi (Taipei) 1999, 62:327-333.
24. Smedile A., Farci P., Verme G., Caredda F., Cargnel A., Caporaso N., et al. Influence of delta infection on severity of hepatitis B. Lancet 1982, 2:945-947.
25. Trey C., Davidson C.S. The management of fulminant hepatic failure. Prog Liver Dis 1970, 3:282-298.
26. Madan K., Gopalkrishna V., Kar P., Sharma J.K., Das U.P., Das B.C. Detection of hepatitis C and E virus genomes in sera of patients with acute viral hepatitis and fulminant hepatitis by their simultaneous amplification in PCR. J Gastroenterol Hepatol 1998, 13:125-130.
27. Singh M., Giri S.K., Ramachandran K. Intrauterine growth curves of live born single babies. Indian Pediatr 1974, 11:475-479.
28. Bile K., Isse A., Mohamud O., Allebeck P., Nilsson L., Norder H., et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg 1994, 51:466-474.
29. Kumar A., Beniwal M., Kar P., Sharma J.B., Murthy N.S. Hepatitis E in pregnancy. Int J Gynaecol Obstet 2004, 85:240-244.
30. Smith J.L. A review of hepatitis E virus. J Food Prot 2001, 64:572-586.
31. Bose P.D., Das B.C., Kumar A., Gondal R., Kumar D., Kar P. High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome. J Hepatol 2011, 54:1107-1113.
32. Arankalle V.A., Chadha M.S., Dama B.M., Tsarvey S.A., Purcell R.M., Banerjee K. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J Viral Hepat 1998, 5:199-204.
33. Saravanabalaji S., Tripathy A.S., Dhoot R.R., Chadha M.S., Kakrani A.L., Arankalle V.A. Viral load, antibody titers and recombinant open reading frame 2 protein-induced Th1/Th2Cytokines and cellular immune responses in self-limiting and fulminant hepatitis E. Intervirology 2009, 52:78-85.
34. Sekiyama K.D., Yoshiba M., Thomson W. Circulating proinflammatory cytokines (IL1-β, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-lRa) in fulminant failure and acute hepatitis. Clin Exp Immunol 1994, 98:71-77.
35. Singhal S., Chakravarty A., Das B.C., Kar P. Tumour necrosis factor-alpha and soluble Fas ligand as biomarkers in non-acetaminophen-induced acute liver failure. Biomarkers 2009, 14:347-353.
36. Keelan J.A., Blumenstein M., Helliwell R.J., Sato T.A., Marvin K.W., Mitchell M.D. Cytokines, prostaglandins and parturition-a review. Placenta 2003, 24(Suppl. A):S33-S46.
37. Inglis S.R., Jeremias J., Kuno K., Lescale K., Peeper Q., Chervenak F.A., et al. Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol 1994, 171:5-10.
38. Kilani R.T., Mackova M., Davidge S.T., Winkler-Lowen B., Demianczuk N., Guilbert L.J. Endogenous tumor necrosis factor alpha mediates enhanced apoptosis of cultured villous trophoblasts from intrauterine growth-restricted placentae. Reproduction 2007, 133:257-264.
39. Bowen J.M., Chamley L., Keelan J.A., Mitchell M.D. Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. Placenta 2002, 23:257-273.
40. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol Today 1993, 14:353-356.